IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Krensavage Asset Management, LLC

Q1 2017 Holdings

Filed 2017-05-15 | 15 holdings | $16.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Conmed Corp(CNMD)COM207410101$15.8M356,30498.2%
Bioverativ IncCOM97075E100$40.7K746,4450.3%
Gilead Sciences Inc(GILD)COM375558103$36.5K537,0210.2%
Enanta Pharmaceuticals Inc(ENTA)COM29251M106$33.8K1,098,5240.2%
United Therapeutics Corp(UTHR)COM91307C102$31.8K234,7430.2%
Sucampo PharmaceuticalsCOM864909106$30.8K2,803,1380.2%
Orthofix International NVCOMN6748L102$26.6K697,3780.2%
Merck & Co. Inc.(MRK)COM58933Y105$24.5K384,8060.2%
Halyard Health IncCOM40650V100$22.3K584,5640.1%
RTI Surgical IncCOM74975N105$17.8K4,438,9500.1%
Invacare CorpCOM461203101$13.7K1,150,6290.1%
Amgen Inc(AMGN)COM031162100$11.2K68,0150.1%
Aviragen Therapeutics IncCOM053761102$1.8K2,836,3260.0%
Digirad CorpCOM253827109$1.8K334,1790.0%
Juniper Pharmaceuticals IncCOM48203L107$1.2K243,1280.0%